ICU · Respiratory / ventilation
Pulmonary Hypertension & Cor Pulmonale
Also known as Pulmonary hypertension · PH · Cor pulmonale · Right ventricular failure · Acute cor pulmonale · Pulmonary arterial hypertension · PAH · WHO groups · CTEPH · Vasopressin for RV failure
Pulmonary hypertension (a mean pulmonary artery pressure above 20 mmHg) is classified into five WHO groups: pulmonary arterial hypertension (group 1), left heart disease (2), lung disease and hypoxia (3), chronic thromboembolic (4), and multifactorial (5). Cor pulmonale is the right-ventricular hypertrophy, dilation, and failure from the pulmonary hypertension, classically from lung disease (group 3). The thin-walled right ventricle tolerates volume but not pressure: a rising pulmonary vascular resistance causes it to dilate and fail, the septum bows into the left ventricle (the D-shaped septum), the left-sided output falls, and tricuspid regurgitation worsens. The ICU management optimises the preload (diurese, do not overfill), reduces the afterload (inhaled nitric oxide, prostacyclin, PDE5 inhibitors), supports the contractility (milrinone, dobutamine), and maintains the systemic blood pressure to preserve the RV coronary perfusion — vasopressin is preferred, as it raises the systemic vascular resistance without raising the pulmonary.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Meet the patient
A patient with scleroderma and progressive breathlessness is admitted with hypotension, a rising lactate, loud pulmonary component of the second heart sound and a dilated right ventricle on echo. The team debates whether to give a fluid challenge or a diuretic.[2]
The right ventricle is volume-intolerant but preload-dependent. The right move is to reduce filling pressure, lower the pulmonary vascular resistance and keep the systemic pressure high enough to perfuse it. Adding more fluid here ends in arrest.[2][11]
References26ShowHide
- [1]Ware LR, Kim CS, et al. A Narrative Review on the Administration of Inhaled Prostaglandins in Critically Ill Adult Patients With Acute Respiratory Distress Syndrome Ann Pharmacother, 2024.PMID 37589097
- [2]Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J, 2023.PMID 36028254
- [3]Galiè N, Barberà JA, Frost AE, et al. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension N Engl J Med, 2015.PMID 26308684
- [4]Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension N Engl J Med, 2013.PMID 23984728
- [5]Sitbon O, Channick R, Chin KM, et al. Selexipag for the Treatment of Pulmonary Arterial Hypertension N Engl J Med, 2015.PMID 26699168
- [6]Ghofrani HA, Galiè N, Grimminger F, et al. Riociguat for the treatment of pulmonary arterial hypertension N Engl J Med, 2013.PMID 23883378
- [7]Ghofrani HA, D'Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension N Engl J Med, 2013.PMID 23883377
- [8]Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med, 2005.PMID 16291984
- [9]Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension N Engl J Med, 2002.PMID 11907289
- [10]Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med, 1996.PMID 8532025
- [11]Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review Crit Care, 2010.PMID 20858239
- [12]Ventetuolo CE, Klinger JR Management of acute right ventricular failure in the intensive care unit Ann Am Thorac Soc, 2014.PMID 24828526
- [13]Harjola VP, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology Eur J Heart Fail, 2016.PMID 26995592
- [14]Kularatne M, Gerges C, Jevnikar M, et al. Updated Clinical Classification and Hemodynamic Definitions of Pulmonary Hypertension and Its Clinical Implications J Cardiovasc Dev Dis, 2024.PMID 38535101
- [15]Sitbon O, Humbert M, Jaïs X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation, 2005.PMID 15939821
- [16]Galiè N, Müller K, Scalise AV, et al. PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension Eur Respir J, 2015.PMID 25657022
- [17]Segal ES, Valette C, Oster L, et al. Risk management strategies in the postmarketing period: safety experience with the US and European bosentan surveillance programmes Drug Saf, 2005.PMID 16231952
- [18]Torres F, Rubin LJ Treprostinil for the treatment of pulmonary arterial hypertension Expert Rev Cardiovasc Ther, 2013.PMID 23259441
- [19]Yang J, Madani MM, Mahmud E, et al. Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension Chest, 2023.PMID 36990148
- [20]Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension Eur Respir J, 2021.PMID 33334946
- [21]Madani MM Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020 Pulm Circ, 2021.PMID 34104418
- [22]Jenkins DP, Martinez G, Salaunkey K, et al. Perioperative Management in Pulmonary Endarterectomy Semin Respir Crit Care Med, 2023.PMID 37487525
- [23]Bourg T, Bell CM, McMurray J, et al. Incidence of Methemoglobinemia in Cardiothoracic Surgery ICU Patients on Inhaled Nitric Oxide Ann Pharmacother, 2026.PMID 40542744
- [24]Searcy RJ, Morales JR, Ferreira JA The role of inhaled prostacyclin in treating acute respiratory distress syndrome Ther Adv Respir Dis, 2015.PMID 26294418
- [25]Strickland B, Albala L, Coffey EC, et al. Safety and practicality of high dose inhaled nitric oxide in emergency department COVID-19 patients Am J Emerg Med, 2022.PMID 35623183
- [26]Clifton J 2nd, Leikin JB Methylene blue Am J Ther, 2003.PMID 12845393